title: Summary of the National Institutes of Health workshop on primary human immunodeficiency virus type 1 infection.
abstract: A Workshop on primary human immunodeficiency virus type 1 (HIV-1) infection sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) and the Office of AIDS Research (OAR) of the National Institutes of Health (NIH) was held February 25-26, 1993 in Bethesda, Maryland. The major goals of this scientific meeting were to bring together researchers and infectious disease specialists who have expertise in primary HIV-1 infection (PHI) to review the pathogenesis of PHI, the treatment experience of PHI in humans and of early retroviral infection in animal models, and to devise theoretical and operational strategies for future clinical trials relating to therapeutic intervention of PHI. The proceedings of this workshop are timely and serve to further the development of innovative strategies for the treatment of HIV-1 infection.
authors.affiliation: Medical Branch, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland 20892.
authors.forename: M T
authors.initials: MT
authors.lastname: Niu
authors.forename: J A
authors.initials: JA
authors.lastname: Jermano
authors.forename: P
authors.initials: P
authors.lastname: Reichelderfer
authors.forename: S M
authors.initials: SM
authors.lastname: Schnittman
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D015658:HIV Infections / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D015497:HIV-1; D006801:Humans; D008253:Macaca mulatta; D016097:Simian Acquired Immunodeficiency Syndrome / Q000276:immunology
chemical_list: D000998:Antiviral Agents